SIVAPRASAD, Sobha, Philip HYKIN, A. SAEED, Stephen BEATTY, Salvatore GRISANTI, Giovanni STAURENGHI, Jose Louis OLEA, A. CAMPOS and Petr KOLÁŘ. Intravitreal pegaptanib sodium for choroidal neovascularisation secondary to age-related macular degeneration : Pan-European experience. EYE. LONDON: Nature Publishing Group, 2010, 24, 2010, No 5, p. 793-798, 5 pp. ISSN 0950-222X.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Intravitreal pegaptanib sodium for choroidal neovascularisation secondary to age-related macular degeneration : Pan-European experience
Name in Czech Intravitreálně podaný pegaptanib sodný pro léčbu chorioideální neovaskularizace na podkladě věkem podmíněné makulární degenerace : panevropská zkušenost
Authors SIVAPRASAD, Sobha (826 United Kingdom of Great Britain and Northern Ireland), Philip HYKIN (826 United Kingdom of Great Britain and Northern Ireland), A. SAEED (372 Ireland), Stephen BEATTY (372 Ireland), Salvatore GRISANTI (276 Germany), Giovanni STAURENGHI (380 Italy), Jose Louis OLEA (724 Spain), A. CAMPOS (620 Portugal) and Petr KOLÁŘ (203 Czech Republic, guarantor, belonging to the institution).
Edition EYE, LONDON, Nature Publishing Group, 2010, 0950-222X.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 1.860
RIV identification code RIV/00216224:14110/10:00044421
Organization unit Faculty of Medicine
UT WoS 000277592900007
Keywords (in Czech) chorioideální neovaskularizace; makulární degenerace; pegaptanib
Keywords in English choroidal neovascularisation; macular degeneration; pegaptanib
Tags International impact, Reviewed
Changed by Changed by: prof. MUDr. Petr Kolář, Ph.D., učo 63563. Changed: 29/10/2012 10:22.
Abstract
Purpose To evaluate visual outcomes in patients with neovascular age-related macular degeneration (NV-AMD) who were treated with pegaptanib sodium in European clinical ophthalmology practices.
Abstract (in Czech)
Cílem je ověřit úroveň zrakové ostrosti u pacientů s neovaskulární věkem podmíněnou makulární degenerací, kteří byli léčeni pegaptanibem sodným v evropských klinických centrech.
PrintDisplayed: 9/7/2024 14:42